POLB — Poolbeg Pharma Share News
0.000.00%
- £64.50m
- £52.33m
REG - Poolbeg Pharma PLC - Price Monitoring Extension
AnnouncementREG - Poolbeg Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Poolbeg Pharma PLC - Positive Initial Data Analysis in POLB 001 Trial
AnnouncementREG - Poolbeg Pharma PLC - Poolbeg identifies novel RSV drug candidates
AnnouncementREG - Poolbeg Pharma PLC - Metabolic diseases oral delivery licence signed
AnnouncementREG - Poolbeg Pharma PLC - Price Monitoring Extension
AnnouncementREG - Poolbeg Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Poolbeg Pharma PLC - POLB 001 LPS human challenge trial completed
AnnouncementRCS - Poolbeg Pharma PLC - Influenza AI model build completed
AnnouncementREG - Poolbeg Pharma PLC - Price Monitoring Extension
AnnouncementREG - Poolbeg Pharma PLC - Price Monitoring Extension
AnnouncementREG - Poolbeg Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Poolbeg Pharma PLC - Capital Markets Day
AnnouncementREG - Poolbeg Pharma PLC - Poolbeg-led consortium awarded EUR 2.3m grant
AnnouncementREG - Poolbeg Pharma PLC - AI programme yields novel RSV drug targets
AnnouncementRCS - Poolbeg Pharma PLC - Upcoming events participation
AnnouncementREG - Poolbeg Pharma PLC - Price Monitoring Extension
AnnouncementREG - Poolbeg Pharma PLC - Second Price Monitoring Extn
AnnouncementREG - Poolbeg Pharma PLC - CEO Share Purchase
Announcement